"Latent Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Descriptor ID |
D055985
|
| MeSH Number(s) |
C01.252.410.040.552.846.122
|
| Concept/Terms |
Latent Tuberculosis- Latent Tuberculosis
- Latent Tuberculoses
- Tuberculoses, Latent
- Tuberculosis, Latent
- Latent Tuberculosis Infection
- Infection, Latent Tuberculosis
- Infections, Latent Tuberculosis
- Latent Tuberculosis Infections
- Tuberculosis Infection, Latent
- Tuberculosis Infections, Latent
|
Below are MeSH descriptors whose meaning is more general than "Latent Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Latent Tuberculosis".
This graph shows the total number of publications written about "Latent Tuberculosis" by people in this website by year, and whether "Latent Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 1 | 4 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 0 | 3 |
| 2019 | 3 | 1 | 4 |
| 2020 | 4 | 1 | 5 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Latent Tuberculosis" by people in Profiles.
-
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis. Clin Infect Dis. 2023 09 18; 77(6):892-900.
-
Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine. Contemp Clin Trials. 2023 06; 129:107173.
-
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis. Lancet Respir Med. 2023 09; 11(9):782-790.
-
Mycobacterium tuberculosis-specific cytokine responses according to HIV status among household contacts of people with TB. Tuberculosis (Edinb). 2023 03; 139:102328.
-
Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial. J Acquir Immune Defic Syndr. 2022 12 01; 91(4):397-402.
-
Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach. BMC Immunol. 2021 09 17; 22(1):63.
-
Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppression. Tuberculosis (Edinb). 2021 01; 126:102023.
-
Mycobacterium tuberculosis infection is associated with increased B cell responses to unrelated pathogens. Sci Rep. 2020 08 31; 10(1):14324.
-
Diagnostic accuracy of plasma kynurenine/tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosis. Int J Infect Dis. 2020 Oct; 99:441-448.
-
Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda. Front Immunol. 2020; 11:929.